308 related articles for article (PubMed ID: 7606651)
1. Renin, kallikrein and prostaglandin renal systems in normotensive boys with and without a family history of essential hypertension.
Rey C; Santos F; Málaga S; Orejas G; Simarro M; Crespo M
J Cardiovasc Risk; 1995 Apr; 2(2):143-8. PubMed ID: 7606651
[TBL] [Abstract][Full Text] [Related]
2. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
Marzecka J
Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
[TBL] [Abstract][Full Text] [Related]
3. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
[TBL] [Abstract][Full Text] [Related]
4. Renal kallikrein-kinin, prostaglandin E2, and dopamine systems in young normotensive subjects with a family history of essential hypertension.
Shimamoto K; Ura N; Nishimura M; Iimura O
Am J Med Sci; 1994 Feb; 307 Suppl 1():S70-4. PubMed ID: 8141169
[TBL] [Abstract][Full Text] [Related]
5. Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents.
van Hooft IM; Grobbee DE; Derkx FH; de Leeuw PW; Schalekamp MA; Hofman A
N Engl J Med; 1991 May; 324(19):1305-11. PubMed ID: 2017226
[TBL] [Abstract][Full Text] [Related]
6. Urinary kallikrein activity in the hypertension of renal parenchymal disease.
Mitas JA; Levy SB; Holle R; Frigon RP; Stone RA
N Engl J Med; 1978 Jul; 299(4):162-5. PubMed ID: 661889
[TBL] [Abstract][Full Text] [Related]
7. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
[TBL] [Abstract][Full Text] [Related]
8. [Hypertensive subpopulations as defined by their natriuretic response to ambulation].
Martín-Sanz V; Pàmies E; Muñiz-Grijalvo O; Stieffel P; Miranda ML; Villar J; Jiménez L; García de Pesquera F; Carneado J
Med Clin (Barc); 1997 Jan; 108(2):50-3. PubMed ID: 9064417
[TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin and kallikrein-kinin systems in sodium homeostasis and hypertension in rats.
Johnston CI; Matthews PG; Dax E
Clin Sci Mol Med Suppl; 1976 Dec; 3():283s-286s. PubMed ID: 1071628
[TBL] [Abstract][Full Text] [Related]
10. Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.
Zacharieva S; Torbova S; Orbetzova M; Borissova AM; Andonova K; Sheitanova S
Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):205-9. PubMed ID: 8738072
[TBL] [Abstract][Full Text] [Related]
11. Acute effect of furosemide on renal kallikrein and prostaglandin systems in mild to moderate essential hypertension.
Franchi F; Lo Sapio P; Strazzulla G; Fabbri G; Scardi A; Pinzani M; Laffi G; Mannelli M
Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):44-9. PubMed ID: 3549580
[TBL] [Abstract][Full Text] [Related]
12. Renal kallikrein excretion in alcoholic cirrhosis. Relationship to other vasoactive systems.
Zipser RD; Kerlin P; Hoefs JC; Zia P; Barg A
Am J Gastroenterol; 1981 Mar; 75(3):183-7. PubMed ID: 7015845
[TBL] [Abstract][Full Text] [Related]
13. Relationship between blood pressure and renin, angiotensin II and atrial natriuretic factor after renal transplantation.
Hestin D; Mertes PM; Hubert J; Claudon M; Mejat E; Renoult E; Pertek JP; Frimat L; Burlet C; Kessler M
Clin Nephrol; 1997 Aug; 48(2):98-103. PubMed ID: 9285146
[TBL] [Abstract][Full Text] [Related]
14. Urinary kallikrein excretion is low in malignant essential hypertension.
Hilme E; Herlitz H; Gyzander E; Hansson L
J Hypertens; 1992 Aug; 10(8):869-74. PubMed ID: 1325521
[TBL] [Abstract][Full Text] [Related]
15. The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Manunta F; Rubatti S; Rappelli A
Agents Actions Suppl; 1987; 22():373-80. PubMed ID: 2449054
[TBL] [Abstract][Full Text] [Related]
16. Urinary and renal kallikrein in hypertensive fawn-hooded (FH/Wjd) rats.
Gilboa N; Rudofsky U; Magro A
Lab Invest; 1984 Jan; 50(1):72-8. PubMed ID: 6363817
[TBL] [Abstract][Full Text] [Related]
17. Loss of sodium modulation of plasma kinins in human hypertension.
Murphey LJ; Eccles WK; Williams GH; Brown NJ
J Pharmacol Exp Ther; 2004 Mar; 308(3):1046-52. PubMed ID: 14718610
[TBL] [Abstract][Full Text] [Related]
18. A renal abnormality in the Milan hypertensive strain of rats and in humans predisposed to essential hypertension.
Bianchi G; Ferrari P; Salvati P; Salardi S; Parenti P; Cusi D; Guidi E
J Hypertens Suppl; 1986 Oct; 4(3):S33-6. PubMed ID: 3537235
[TBL] [Abstract][Full Text] [Related]
19. Developmental patterns of blood pressure and urinary protein, kallikrein, and prostaglandin E2 in Dahl salt-hypertension-susceptible rats.
Sustarsic DL; McPartland RP; Rapp JP
J Lab Clin Med; 1981 Oct; 98(4):599-606. PubMed ID: 6912875
[TBL] [Abstract][Full Text] [Related]
20. [The role of renal vasodepressor and natriuretic systems and ouabain-like factor on the early phase of hypertension in two-kidney, one-clip hypertensive rats].
Torii T; Ura N; Takizawa H; Shimamoto K
Nihon Jinzo Gakkai Shi; 2001 Nov; 43(8):631-8. PubMed ID: 11808073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
